PRESSUREWIRE™ X GUIDEWIRE FOR IMPROVED CARDIAC CATH LAB WORKFLOW
Using existing hardware and screens, the PressureWire™ X Guidewire displays FFR or RFR measurements in the cardiac cath lab as well as the control room. All FFR/RFR results are stored with procedural data to provide a complete patient record.
In addition, the PressureWire™ X Guidewire requires no stand-alone FFR/RFR instrumentation or time-consuming setup. The secure, wireless technology eliminates cables crossing the sterile field, and there is no cable to limit wire maneuverability.
This newest generation of PressureWire™ X Guidewire technology offers:
- Four connectivity options to measure both FFR and RFR
- A hydrophilic coating that significantly lowers friction and enables smoother stent delivery and better overall maneuverability2
- Improved shapeability and reshapeability for smooth navigation2
- Better shape retention for performance in complex anatomy and for multiple pull-backs2
- More durable soft tip designed to protect the vessel in tortuous anatomy without compromising steerability/trackability2
- Wireless technology for ease of use when employing a radial approach
- Drift reduction, which can minimize drift and therefore operator error for FFR/RFR measurements3
ACCURATE AND RELIABLE
The PressureWire™ X Guidewire is the only pressure wire technology clinically proven in both FAME and FAME 2 studies.4-6
1. Volcano Corp. Verrata‡ guidewire and PrimeWire Prestige‡ Plus guidewire IFUs, Opsens Inc. OptoWire‡ guidewire and OptoWire‡ II guidewire IFUS, ACIST Medical Systems. Navvus‡ Microcatheter IFU, Boston Scientific Corporation. Comet‡ guidewire IFU, PressureWire™ X guidewire IFU.
2. Test(s) performed by and data on file at Abbott.
3. Compared to the previous generation (PressureWire™ 8 Guidewire); Test(s) performed by and data on file at Abbott.
4. Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary iIntervention. New Engl J Med. 2009;360:213-224. doi: 10.1056/NEJMoa0807611.
5. Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME study. J Am Coll Cardiol. 2010;56(3):177-184. doi: 10.1016/j.jacc.2010.04.012.
6. de Bruyne B, et al. Fractional flow reserve–guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367(11), 991–1001. doi: 10.1056/NEJMoa1205361.